课题基金 / 基金详情

Investigating variation in the inpatient allocation of scarce COVID-19 therapeutics: Equity and Clinical Outcomes

Investigating variation in the inpatient allocation of scarce COVID-19 therapeutics: Equity and Clinical Outcomes
调查稀缺 COVID-19 疗法住院患者分配的变化:公平性和临床结果
批准号:
465297
负责人:
Razak Fahad
金额:
$29.14万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-03-01 至 2024-03-01

项目摘要

项目成果

Razak Fahad的其他基金

相关文献

中文摘要
翻译
新冠肺炎大流行导致迫切需要有效的治疗方法来治疗严重感染的住院患者。在不到两年的时间里,新药被开发出来,现有的药物被改变了用途,以提供一系列有效的树
英文摘要
The COVID-19 pandemic resulted in an urgent need for effective therapeutics to treat hospitalized patients with severe infections. In less than two years, new drugs were developed and existing medications were repurposed to provide a range of effective tr
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A pragmatic randomized trial to evaluate the effect of a peer-comparison feedback letter on antimicrobial use in hospital-based physicians
  • 批准号:
    483302
  • 项目类别:
    Operating Grants
  • 资助金额:
    $21.86万
  • 财政年份:
    2023
  • 负责人:
    Razak Fahad
  • 依托单位:
A pragmatic randomized trial to evaluate the effect of a peer-comparison feedback letter on antimicrobial use in hospital-based physicians
  • 批准号:
    490409
  • 项目类别:
    Operating Grants
  • 资助金额:
    $46.26万
  • 财政年份:
    2023
  • 负责人:
    Razak Fahad
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    471126
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    2022
  • 负责人:
    Razak Fahad
  • 依托单位:
Investigating variation in the inpatient allocation of scarce COVID-19 therapeutics: Equity and Clinical Outcomes
  • 批准号:
    473341
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Razak Fahad
  • 依托单位: